3.17
-0.04 (-1.19%)
| Penutupan Terdahulu | 3.21 |
| Buka | 3.21 |
| Jumlah Dagangan | 8,866 |
| Purata Dagangan (3B) | 263,078 |
| Modal Pasaran | 61,858,932 |
| Harga / Buku (P/B) | 2.90 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Aug 2025 |
| EPS Cair (TTM) | -1.96 |
| Nisbah Semasa (MRQ) | 0.220 |
| Aliran Tunai Operasi (OCF TTM) | -10.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 3.23 M |
| Pulangan Atas Aset (ROA TTM) | -191.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | NRX Pharmaceuticals, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 0.0 |
| Purata | 1.38 |
|
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 15.88% |
| % Dimiliki oleh Institusi | 13.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| One Wealth Management Investment & Advisory Services, Llc | 31 Mar 2025 | 15,041 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 46.00 (Ascendiant Capital, 1,350.33%) | Beli |
| Median | 38.50 (1,113.86%) | |
| Rendah | 31.00 (D. Boral Capital, 877.39%) | Beli |
| Purata | 38.50 (1,113.86%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 2.58 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 23 Jun 2025 | 31.00 (877.39%) | Beli | 3.10 |
| 20 Jun 2025 | 31.00 (877.39%) | Beli | 3.26 | |
| Ascendiant Capital | 29 Apr 2025 | 46.00 (1,350.33%) | Beli | 2.06 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |